Earlier this year, I called on 6 big pharmaceutical companies to stop anticompetitive practices that keep asthma inhaler prices high. Now, @AstraZeneca is the second company to cap patients' out-of-pocket costs for its inhalers at $35. Let's keep this momentum going!
Earlier this year, I called on 6 big pharmaceutical companies to stop anticompetitive practices that keep asthma inhaler prices high. Now, @AstraZeneca is the second company to cap patients' out-of-pocket costs for its inhalers at $35. Let's keep this momentum going!
@SenAmyKlobuchar @AstraZeneca There is no momentum they all laugh at you.
@SenAmyKlobuchar @AstraZeneca I have Medicare and supplement insurance. I use these inhalers and pay $49 each until I reach a donut hole. Then over $100 each, which is over half the year.